- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03791645
Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction (SKY)
October 11, 2022 updated by: Ohio State University
Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction, In Adults Undergoing Opioid Addiction Treatment
This study demonstrates the feasibility, acceptability of SKY program as an adjuvant therapy for American population suffering with OUD through a pilot program in Columbus, Ohio.
The aim of this study is to evaluate the SKY program as an adjuvant therapy to treat opioid addiction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This research proposal aims to test the feasibility, acceptability and efficacy of SKY (Sudarshan Kriya Yoga) program, a mind-body intervention, as an adjuvant therapy for people suffering with opioid use disorder (OUD), in Columbus, Ohio.
Previous research carried out in India in 2015, has demonstrated that SKY significantly improved the quality of life among people with OUD, however, the suitability, acceptability of SKY program has not been tested among American population.
SKY differs from mindfulness and other meditation processes in that, it is a more physiological, rather than cognitive process.
It involves controlled breathing techniques that can be easily mastered, and do not require mental effort.
The investigator's goals are to a) DEMONSTRATE the feasibility, acceptability and efficacy of SKY program as an adjuvant therapy for American population suffering with OUD.
Studies will be carried out in OUD subjects at Mary Haven clinic in Columbus.
The efficacy of SKY will be measured using psychometric questionnaires.
Feasibility and acceptability will be measured by attendance and attrition.
Study Type
Interventional
Enrollment (Actual)
61
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University College of Social Work
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The proposed participants are currently residents of Mary Haven
- Are currently undergoing addiction treatment which may include medication assisted treatment as well as counseling.
- The intervention is designed for adults, therefore, only individuals 18 and above will be included in the study.
Exclusion Criteria:
- Pregnant women who are beyond their first trimester are excluded from the study as the program requires breathing techniques that are not recommended for pregnant women.
- Also, patients diagnosed with schizophrenia and bipolar disorder will also be excluded from the study, as SKY program is not suitable for people with these conditions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: SKY Intervention
Participants in the intervention group will get to participate in the SKY program, for 5 days with each day session taking 3 hours/day.
SKY program involves a) specific breathing exercises and social interaction with other participants in the program.
Following completion of the program, another set of questionnaires will be administered to collect information regarding stress, mood, and opioid use.
After completion of the 5 day SKY program, participants will practice SKY every day at home for 30 days.
They will also need to attend 4 weekly group sessions during this period and each session is expected to last 1 hour.
At the end of the 30 day period, another set of questionnaires will be administered to collect information regarding stress, mood, and opioid use.
|
SKY meditation has three sequential components of breathing interspersed with normal breathing.
These include a) sound breath: breathing against airway resistance with slight tightening of the laryngeal muscles, (2-3 cycles/min) followed by b) bellows breath: rapid, forced expiration(20-30 cycles/min) and c) regulated, rhythmical breathing rotating through medium to fast cycles.
Each session is focused upon proper breathing techniques, social interaction, and discussion of practical wisdom for everyday life to manage the mind and emotions.
SKY will be administered over a 5 day period (~3 hours/day), followed by 4 weekly follow-ups (~90 min session/week) at Signature Health clinic situated in Ashtabula, Ohio.
|
|
NO_INTERVENTION: Usual treatment
Participants assigned to the control group will not have access to the SKY program but will continue with usual care.
They will also complete questions after 5 days and again after 30 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in psychological health following the Sudarshan Kriya Yoga (SKY) therapy
Time Frame: Before SKY intervention, 1 hour after intervention and 1 month after intervention
|
Change in psychological health will be measured using psychometric test administered to subjects at Signature Health clinic in Ashtabula, Ohio.
The Pychometric test will involve completion of a Basic 24 Questionnaire: It is a leading behavioral health assessment tool which consists of 24 questions that cover depression and functioning.
|
Before SKY intervention, 1 hour after intervention and 1 month after intervention
|
|
Change in the number of participants that complete the Sudarshan Kriya Yoga (SKY) therapy
Time Frame: Time 1 = initial therapy session, Time 2 = week 1 post therapy session, Time 3 = week 2 post therapy session Time 4 = week 3 post therapy session, Time 5 = week 4 post therapy session Time 6 = 30 minutes daily home practice for 30 days
|
To study the acceptability of the SKY program as an adjuvant therapy for American population suffering with mental disorders + opioid addiction, the attendance and attrition of the subjects at the Signature Health clinic in Ashtabula in the SKY therapy sessions will be recorded by keeping record of those that complete each progressive therapy session.
|
Time 1 = initial therapy session, Time 2 = week 1 post therapy session, Time 3 = week 2 post therapy session Time 4 = week 3 post therapy session, Time 5 = week 4 post therapy session Time 6 = 30 minutes daily home practice for 30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Keith Warren, PhD, Ohio State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 27, 2018
Primary Completion (ACTUAL)
March 31, 2022
Study Completion (ACTUAL)
March 31, 2022
Study Registration Dates
First Submitted
November 7, 2018
First Submitted That Met QC Criteria
December 31, 2018
First Posted (ACTUAL)
January 2, 2019
Study Record Updates
Last Update Posted (ACTUAL)
October 13, 2022
Last Update Submitted That Met QC Criteria
October 11, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018H0409
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)CompletedSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
University of Illinois at ChicagoNot yet recruitingHealthy | Cannabis Use | Substance Use Disorder (SUD)United States
-
Spark Biomedical, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baylor College... and other collaboratorsRecruitingSubstance Use Disorders | Alcohol Use Disorder | Alcohol Abuse | Substance Use Disorders Alcohol Use Withdrawal StateUnited States
Clinical Trials on Sky Intervention
-
University of California, San FranciscoActive, not recruiting
-
Skyhawk Therapeutics, Inc.Active, not recruitingHuntington Disease | Huntingtons DiseaseAustralia, New Zealand
-
University of Alabama at BirminghamM.D. Anderson Cancer CenterCompletedStress | Stress, Psychological | Anxiety | Stress, Physiological | Happiness | Resilience | Mental Well BeingUnited States
-
Skyhawk Therapeutics, Inc.RecruitingHuntington DiseaseCanada, Georgia, Argentina, Brazil
-
Skyhawk Therapeutics, Inc.Enrolling by invitationHuntington's Disease (HD)Australia
-
University of Alabama at BirminghamWithdrawnStress, Psychological
-
University of California, Los AngelesCompletedAddiction | Addiction DisordersUnited States
-
Dasman Diabetes InstituteCompletedA Pilot Study on Effect of SKY on Psychosocial Parameters of Type 2 Diabetic Patients After a 6 DaysDiabetes Mellitus, Non-Insulin-DependentKuwait
-
Skylark Bio Inc.RecruitingDFNB1A | GJB2 Gene Mutation | GJB2-mediated Hearing LossUnited States
-
McGill UniversityObservatory for Children's Education and HealthNot yet recruiting